Determinants of Vasospasm and Delayed Ischemic Deficits in Aneurysmal Subarachnoid Hemorrhage
NCT ID: NCT02829398
Last Updated: 2017-05-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
41 participants
INTERVENTIONAL
2008-03-31
2011-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prolonged Vasospasm in Subarachnoid Hemorrhage
NCT04193124
Cerebral Autoregulation in Patients With Aneurysmal SubArachnoid Haemorrhage
NCT03987139
Permanent Cerebral Oxymetry Monitoring for Early Diagnosis and Treatment of Delayed Vasospasm After Subarachnoid Hemorrhage
NCT04042571
CT Perfusion Imaging to Predict Vasospasm in Subarachnoid Hemorrhage
NCT02056769
Computed Tomographic (CT) Perfusion and CT Angiography as Screening Tools for Vasospasm Following Subarachnoid Hemorrhage
NCT00962546
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with subarachnoid hemorrhage
Patients with subarachnoid hemorrhage will have CerebroSpinal fluid and plasma sample.
CerebroSpinal fluid and plasma samples
CerebroSpinal fluid and plasma samples for biological markers
Control subjects
healthy controls from a previous study with a CerebroSpinal fluid and plasma sample
CerebroSpinal fluid and plasma samples
CerebroSpinal fluid and plasma samples for biological markers
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CerebroSpinal fluid and plasma samples
CerebroSpinal fluid and plasma samples for biological markers
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* symptomatic aneurysm treated with endovascular,
* Absence of achieving a lumbar puncture,
* Patients affiliated to a social security scheme,
* Patients who have given their free and informed consent and signed the consent or consent of the family.
Group 2 :
healthy volunteers with cerebrospinal fluid sample
Exclusion Criteria
* Patients with previous disease that might impair cerebral autoregulation (e.g., carotid stenosis, history of stroke or head injury).
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Toulouse
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
LARRUE Vincent, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Toulouse
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital of Toulouse
Toulouse, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Calviere L, Nasr N, Arnaud C, Czosnyka M, Viguier A, Tissot B, Sol JC, Larrue V. Prediction of Delayed Cerebral Ischemia After Subarachnoid Hemorrhage Using Cerebral Blood Flow Velocities and Cerebral Autoregulation Assessment. Neurocrit Care. 2015 Oct;23(2):253-8. doi: 10.1007/s12028-015-0125-x.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Local Grant
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
07 304 02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.